Benefitfocus Buy Hold or Sell Recommendation

BNFT -- USA Stock  

USD 26.43  0.53  2.05%

Given the investment horizon of 30 days, and your above average risk tolerance our recommendation regarding Benefitfocus is 'Strong Hold'. Macroaxis provides Benefitfocus buy hold or sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding BNFT positions. The advice algorithm takes into account all of Benefitfocus available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from BNFT buy-and-hold prospective. Check also Benefitfocus Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for muliple equity instruments please use Instant Ratings tool.

Time Horizon

Risk Tolerance

Symbol
Execute Advice
Sell BenefitfocusBuy Benefitfocus
Strong Hold

Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Piotroski F Score

Financial Leverage

Inapplicable
For the selected time horizon Benefitfocus has a risk adjusted performance of 0.039, jensen alpha of 0.1645, total risk alpha of 0.3639, sortino ratio of 0.0656 and treynor ratio of 0.0985
Macroaxis buy, hold, or sell recommendation module can be used to complement current analysts and expert consensus on Benefitfocus. Our buy, hold, or sell suggestion engine makes use of analyzes the corporation potential to grow using all fundamental data market data available at the time. To make sure Benefitfocus is not overpriced, please confirm all Benefitfocus fundamentals including its Price to Book, Current Ratio, Retained Earnings, as well as the relationship between Net Income and Price to Earnings To Growth . Given that Benefitfocus has Number of Shares Shorted of 4.35M, we suggest you validate Benefitfocus market performance and probability of bankruptcy to make sure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Benefitfocus Trading Alerts and Improvement Suggestions

The company reported previous year revenue of 272.66M. Net Loss for the year was (53.71M) with profit before overhead, payroll, taxes, and interest of 129.44M.
Benefitfocus currently holds about 138.39M in cash with (6.71M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.23.
Roughly 75.0% of the company shares are held by institutions such as insurance companies

Benefitfocus current analysts recommendations

Target Median Price46.50
Target Mean Price46.10
Recommendation Mean2.20
Target High Price59.00
Number Of Analyst Opinions10
Target Low Price30.00

Benefitfocus Returns Distribution Density

Mean Return0.09Value At Risk4.27
Potential Upside5.17Standard Deviation2.76
 Return Density 
      Distribution 

Institutional Investors

Security TypeSharesValue
Fmr LlcCommon Shares4.8 M129.9 M
Bamco IncCommon Shares4.1 M112.5 M
Blackrock IncCommon Shares2.9 M78.7 M
Vanguard Group IncCommon Shares2.5 M66.8 M
Frontier Capital Management Co Llc 1Common Shares2.1 M56.9 M
Artisan Partners Limited PartnershipCommon Shares1.2 M32.2 M
Arrowmark Colorado Holdings LlcCommon Shares1 M27.3 M

Benefitfocus Greeks

α
Alpha over DOW
=0.16
β
Beta against DOW=0.83
σ
Overall volatility
=2.76
Ir
Information ratio =0.07

Benefitfocus Volatility Alert

Benefitfocus currently demonstrates below average downside deviation of 2.77. It has Information Ratio of 0.07 and Jensen Alpha of 0.16. However, we do advice investors to further question Benefitfocus expected returns to make sure all indicators are consistent with the current outlook about its relatively low value at risk.
    
 Better Than Average     
    
 Worse Than Average Compare Benefitfocus to competition

Benefitfocus Fundamental Vs Peers

FundamentalsBenefitfocusPeer Average
Return On Equity(0.0001)% (0.31)%
Return On Asset(8.80)% (0.14)%
Profit Margin(19.70)% (1.27)%
Operating Margin(13.34)% (5.51)%
Current Valuation1.04B16.62B
Shares Outstanding31.76M571.82M
Shares Owned by Insiders26.51% 10.09%
Shares Owned by Institutions74.96% 39.21%
Number of Shares Shorted4.35M4.71M
Price to Earning(29.98)X28.72X
Price to Book254.57X9.51X
Price to Sales3.27X11.42X
Revenue272.66M9.43B
Gross Profit129.44M27.38B
EBITDA(22.15M)3.9B
Net Income(53.71M)570.98M
Cash and Equivalents138.39M2.7B
Cash per Share4.23X5.01X
Total Debt276.43M5.32B
Debt to Equity(11.11)% 48.70%
Current Ratio2.53X2.16X
Book Value Per Share(0.58)X1.93K
Cash Flow from Operations(6.71M)971.22M
Short Ratio10.76X4.00X
Earnings Per Share(1.67)X3.12X
Price to Earnings To Growth(1.55)X4.89X
Number of Employees1.45K18.84K
Beta1.22-0.15
Market Capitalization890.99M19.03B
Total Asset182.12M29.47B
Retained Earnings(194.08M)9.33B
Working Capital18.35M1.48B
Current Asset123.94M9.34B
   Benefitfocus exotic insider transaction detected [view details]
Search macroaxis.com